Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

BACKGROUND: Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD). A pilot trial of the tetracycline minocycline as adjunctive treatment in treatment-resistant depression (TRD), produced promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Husain, Muhammad Ishrat, Cullen, Clare, Umer, Madeha, Carvalho, Andre F., Kloiber, Stefan, Meyer, Jeffrey H., Ortiz, Abigail, Knyahnytska, Yuliya, Husain, M. Omair, Giddens, Justine, Diniz, Breno S., Wang, Wei, Young, Allan H., Mulsant, Benoit H., Daskalakis, Zafiris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161279/
https://www.ncbi.nlm.nih.gov/pubmed/32295565
http://dx.doi.org/10.1186/s12888-020-02553-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161279/
https://www.ncbi.nlm.nih.gov/pubmed/32295565
http://dx.doi.org/10.1186/s12888-020-02553-9

Ejemplares similares